Turkiye Klinikleri Journal of Health Sciences

.: REVIEW
Osteoartritte Beslenmenin Rolü
Role of Nutrition in Osteoarthritis
Beda Büşra ÖZALPa, Nilgün SEREMET KÜRKLÜa
aAkdeniz Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Antalya, TÜRKİYE
Turkiye Klinikleri J Health Sci. 2020;5(3):661-70
doi: 10.5336/healthsci.2020-73626
Article Language: TR
Full Text
ÖZET
 Osteoartrit (OA), en yaygın artrit türüdür. Ayrıca hareket yetersizliklerine neden olan sebeplerden en hızlı artanıdır. 2050 yılında, yaklaşık 130 milyon insanın önemli bir toplumsal sorun olan osteoartritten zarar göreceği belirtilmektedir. Dünyada, 60 yaş üstü kadınların %18'i ve erkeklerin ise %9,6'sı semptomatik OA'ya sahiptir ve bu kişilerin 1/4'ü günlük rutin aktivitelerini gerçekleştirememektedir. OA, subkondral kemiğin yeniden şekillenmesi, sinoviyal inflamasyon ve eklem kıkırdak kaybını içeren multifaktöriyel bir hastalıktır. İnflamatuar sitokinler, özellikle de interlökin-1β ve tümör nekrozis faktör-α, katabolik yolakları inhibe etmektedir. Obezitede görülen düşük düzeyde sistematik inflamasyon obezitenin, OA için değiştirilebilir bir risk faktörü olduğunu göstermektedir. Uluslararası Osteoartrit Araştırmaları Derneği rehberleri, hafif şişman/obez bireylerde egzersiz ile vücut ağırlığında azalmanın, OA semptomlarının azaltılmasında etkili olabileceğini belirtmiştir. OA'nın semptomlarının hafifletilmesinde, birçok besin grubu veya besin ögesi etkilidir. Yapılan çalışmalarda balık, süt ürünleri, sebze ve meyve gibi besinlerin içerdiği n-3, posa ve antioksidan vitamin ve minerallerden dolayı düzenli tüketilmesinin, OA ile negatif ilişki olduğu gözlenmiştir. Bununla birlikte D ve K vitaminleri yetersizliği ile OA arasında da pozitif ilişki bulunmuştur. Ayrıca çalışmalar sonucunda posa tüketiminin, vücut ağırlığında azalmayı sağlayarak ve inflamasyonu önleyerek OA hastalığı riskini azalttığı belirtilmiştir. Bu verilerden yola çıkarak, yeterli ve dengeli beslenmenin birçok hastalıkta olduğu gibi OA riskinde ve tedavi yönetiminde etkili olabileceği düşünülmektedir. Bu çalışmada enerji, makro ve mikro besin ögelerinin, OA oluşumunda veya tedavisindeki rolünün açıklanması amaçlanmıştır.

Anahtar Kelimeler: Osteoartrit; beslenme; antioksidanlar; obezite
ABSTRACT
 Osteoarthritis (OA) is the most common type of arthritis. In addition, it is the most frequent cause leading to movement impairments. It is stated that about 130 million people will suffer from osteoarthritis, an important social problem, in 2050. Around the world, 18% of women and 9.6% of men over the age of 60 have symptomatic OA, and a quarter of these people are unable to perform daily routine activities. Osteoarthritis is a multifactorial disease involving the remodeling of the subchondral bone, synovial inflammation and loss of joint cartilage. Inflammatory cytokines, particularly interleukin-1β and tumor necrosis factor-α, inhibit catabolic pathways. Low systematic inflammation in obesity suggests that obesity is a modifiable risk factor for OA. Adipokines, hyperglycemia and endocrinological problems have been associated with OA in a number of studies. Osteoarthritis Research Society International guidelines indicate that a decrease in body weight by exercise in overweight/obese individuals may be effective in reducing OA symptoms. Many food groups or nutrients are effective in alleviating the symptoms of osteoarthritis. In studies conducted, it has been observed that regular consumption of foods such as fish, dairy products, vegetables and fruits is negatively associated with OA, due to their content of n-3, fiber and antioxidant vitamins and minerals. Furthermore, a correlation has been found between vitamin D and K deficiency and OA. Also, studies show that the consumption of fiber prevents the risk of OA disease by decreasing body weight and preventing inflammation. Based on these data, adequate and balanced nutrition is considered to be effective in osteoarthritis risk and treatment management as in many diseases. In this study, it is aimed to explain the role of energy, macro and micronutrients in OA formation or treatment.

Keywords: Osteoarthritis; nutrition; antioxidants; obesity
REFERENCES:
  1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039-49. [Crossref]  [PubMed] 
  2. Türkiye İstatistik Kurumu. İstatistiklerle Yaşlılar. 2017. [Link] 
  3. Wittenauer R, Smith L, Aden K. Background Paper 6.12 Osteoarthritis. priority medicines for europe and the world "a public health approach to ınnovation" update on 2004 background paper, January 28th 2013. World Health Organization. Available from: Last accessed on 2019 Apr 05]. [Link] 
  4. Ünüvar N, Mollahaliloğlu S, Yardım N. Fiziksel İnaktivite. Türkiye Hastalık Yükü Çalışması. 1. Baskı. Ankara: T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı; 2004;1-71.
  5. Murphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008;15;59(9):1207-13. [Crossref]  [PubMed]  [PMC] 
  6. Jordan JM. Epidemiology and classification of osteoarthritis. In: Hochberg MC, Silman AJ, Smolen JS, Winblatt ME, Weisman MH, eds. Rheumatology. Philadelphia: Mosby Elsevier; 2008. p.1691-701.
  7. Spector TD, MacGregor AJ. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage. 2004;12 Suppl A:S39-44. [Crossref]  [PubMed] 
  8. Messier SP. Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management. Rheum Dis Clin North Am. 2008;34(3):713-29. [Crossref]  [PubMed]  [PMC] 
  9. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15(9):981-1000. Epub 2007 Aug 27. [Crossref]  [PubMed] 
  10. Brosseau L, Wells GA, Tugwell P, Egan M, Dubouloz CJ, Casimiro L, et al. Ottawa Panel evidence-based clinical practice guidelines for the management of osteoarthritis in adults who are obese or overweight. Phys Ther. 2011;91(6):843-61. [Crossref]  [PubMed] 
  11. Tantavisut S, Tanavalee A, Honsawek S, Suantawee T, Ngarmukos S, Adisakwatana S, et al. Effect of vitamin E on oxidative stress level in blood, synovial fluid, and synovial tissue in severe knee osteoarthritis: a randomized controlled study. BMC Musculoskelet Disord. 2017;29;18(1):281. [Crossref]  [PubMed]  [PMC] 
  12. Baker K, Niu JB, Goggins J. The effects of vitamin C intake on pain in knee osteoarthritis (OA). Arthritis Rheum. 2003;48:422. [Link] 
  13. Chaganti RK, Parimi N, Cawthon P, Dam TL, Nevitt MC, Lane NE, et al. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: the osteoporotic fractures in men study. Arthritis Rheum. 2010;62(2):511-4. [Crossref]  [PubMed]  [PMC] 
  14. Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851-63. [Crossref]  [PubMed]  [PMC] 
  15. Güven SC, Özdemir O, Dinçer F. [The relationship between osteoarthritis and obesity]. J PMR Sci. 2016;19:76-84. [Crossref] 
  16. Egloff C, Hügle T, Valderrabano V. Biomechanics and pathomechanisms of osteoarthritis. Swiss Med Wkly. 2012;19;142:w13583. [Crossref]  [PubMed] 
  17. Herzog W, Adams ME, Matyas JR, Brooks JG. Hindlimb loading, morphology and biochemistry of articular cartilage in the ACL-deficient cat knee. Osteoarthritis Cartilage. 1993;1(4):243-51. [Crossref]  [PubMed] 
  18. Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C, et al. Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord. 2001;25(5):622-7. [Crossref]  [PubMed] 
  19. Cooper C, Inskip H, Croft P, Campbell L, Smith G, McLaren M, et al. Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol. 1998;15;147(6):516-22. [Crossref]  [PubMed] 
  20. Nevitt MC, Lane N. Body weight and osteoarthritis. Am J Med. 1999;107(6):632-3. [Crossref]  [PubMed] 
  21. Felson DT. Weight and osteoarthritis. Am J Clin Nutr. 1996;63(3 Suppl):430S-2S. [Crossref]  [PubMed] 
  22. March LM, Bagga H. Epidemiology of osteoarthritis in Australia. Med J Aust. 20041;180(S5):S6-10. [Crossref]  [PubMed] 
  23. Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;25;310(12):1263-73. [Crossref]  [PubMed]  [PMC] 
  24. Bartels EM, Christensen R, Christensen P, Henriksen M, Bennett A, Gudbergsen H, et al. Effect of a 16 weeks weight loss program on osteoarthritis biomarkers in obese patients with knee osteoarthritis: a prospective cohort study. Osteoarthritis Cartilage. 2014;22(11):1817-25. [Crossref]  [PubMed] 
  25. Aaboe J, Bliddal H, Messier SP, Alkjær T, Henriksen M. Effects of an intensive weight loss program on knee joint loading in obese adults with knee osteoarthritis. Osteoarthritis Cartilage. 2011;19(7):822-8. [Crossref]  [PubMed] 
  26. Baysal A. Beslenme. Karbonhidratlar. 18.Baskı. Ankara: Hatipoğlu Yayınevi; 2002. p.19-30.
  27. Strath LJ, Jones CD, Philip George A, Lukens SL, Morrison SA, Soleymani T, et al. The effect of low-carbohydrate and low-fat diets on pain in ındividuals with knee osteoarthritis. Pain Med. 2020;1;21(1):150-60. [Crossref]  [PubMed] 
  28. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, et al. Health benefits of dietary fiber. Nutr Rev. 2009;67(4):188-205. [Crossref]  [PubMed] 
  29. Dai Z, Niu J, Zhang Y, Jacques P, Felson DT. Dietary intake of fibre and risk of knee osteoarthritis in two US prospective cohorts. Ann Rheum Dis. 2017;76(12):2103. [Crossref]  [PubMed] 
  30. Dai Z, Lu N, Niu J, Felson DT, Zhang Y. Dietary fiber ıntake in relation to knee pain trajectory. Arthritis Care Res (Hoboken). 2017;69(9):1331-9. [Crossref]  [PubMed]  [PMC] 
  31. Leenders M, Verdijk LB, van der Hoeven L, van Kranenburg J, Nilwik R, van Loon LJ, et al. Elderly men and women benefit equally from prolonged resistance-type exercise training. J Gerontol A Biol Sci Med Sci. 2013;68(7):769-79. [Crossref]  [PubMed] 
  32. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-59. [Crossref]  [PubMed] 
  33. Rizzoli R. Dairy products, yogurts, and bone health. Am J Clin Nutr. 2014;99(5 Suppl):1256S-62S. [Crossref]  [PubMed] 
  34. Rizzoli R, Stevenson JC, Bauer JM, van Loon LJ, Walrand S, Kanis JA, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2015;80(3):337. [Crossref]  [PubMed] 
  35. Arjmandi BH, Khalil DA, Lucas EA, Smith BJ, Sinichi N, Hodges SB, et al. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine. 2004;11(7-8):567-75. [Crossref]  [PubMed] 
  36. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab. 2006;291(2):E381-7. [Crossref]  [PubMed] 
  37. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr. 2005;82(5):1065-73. [Crossref]  [PubMed] 
  38. Ikeda T, Jinno T, Masuda T, Aizawa J, Ninomiya K, Suzuki K, et al. Effect of exercise therapy combined with branched-chain amino acid supplementation on muscle strengthening in persons with osteoarthritis. Hong Kong Physiother J. 2018;38(1):23-31. [Crossref]  [PubMed]  [PMC] 
  39. Masuko K, Murata M, Suematsu N, Okamoto K, Yudoh K, Nakamura H, et al. A metabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. Clin Exp Rheumatol. 2009;27(2):347-53. [PubMed] 
  40. Baker KR, Matthan NR, Lichtenstein AH, Niu J, Guermazi A, Roemer F, et al. Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study. Osteoarthritis Cartilage. 2012;20(5):382-7. [Crossref]  [PubMed]  [PMC] 
  41. Wu CL, Jain D, McNeill JN, Little D, Anderson JA, Huebner JL, et al. Dietary fatty acid content regulates wound repair and the pathogenesis of osteoarthritis following joint injury. Ann Rheum Dis. 2015;74(11):2076-83. [Crossref]  [PubMed]  [PMC] 
  42. Sekar S, Shafie SR, Prasadam I, Crawford R, Panchal SK, Brown L, et al. Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats. Sci Rep. 2017;18;7:46457. [Crossref]  [PubMed]  [PMC] 
  43. Lu B, Driban JB, Xu C, Lapane KL, McAlindon TE, Eaton CB, et al. Dietary fat intake and radiographic progression of knee osteoarthritis: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken). 2017;69(3):368-75. [Crossref]  [PubMed]  [PMC] 
  44. Hill CL, March LM, Aitken D, Lester SE, Battersby R, Hynes K, et al. F Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose. Ann Rheum Dis. 2016;75(1):23-9. [Crossref]  [PubMed] 
  45. Grover AK, Samson SE. Benefits of antioxidant supplements for knee osteoarthritis: rationale and reality. Nutr J. 2016;5;15:1. [Crossref]  [PubMed]  [PMC] 
  46. McAlindon T, Felson DT. Nutrition: risk factors for osteoarthritis. Ann Rheum Dis. 1997;56(7):397-400. [Crossref]  [PubMed]  [PMC] 
  47. De Roos AJ, Arab L, Renner JB, Craft N, Luta G, Helmick CG, et al. Serum carotenoids and radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. Public Health Nutr. 2001;4(5):935-42. [Crossref]  [PubMed] 
  48. Seki T, Hasegawa Y, Yamaguchi J, Kanoh T, Ishiguro N, Tsuboi M, et al. Association of serum carotenoids, retinol, and tocopherols with radiographic knee osteoarthritis: possible risk factors in rural Japanese inhabitants. J Orthop Sci. 2010;15(4):477-84. [Crossref]  [PubMed] 
  49. Mabey T, Honsawek S. Role of vitamin D in osteoarthritis: molecular, cellular, and clinical perspectives. Int J Endocrinol. 2015;2015:383918. [Crossref]  [PubMed]  [PMC] 
  50. Shen M, Luo Y, Niu Y, Chen L, Yuan X, Goltzman D, et al. 1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via secretion of senescence-associated inflammatory cytokines. Bone. 2013;55(2):400-9. [Crossref]  [PubMed] 
  51. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99(11):4336-45. [Crossref]  [PubMed] 
  52. Tomlinson PB, Joseph C, Angioi M. Effects of vitamin D supplementation on upper and lower body muscle strength levels in healthy individuals. A systematic review with meta-analysis. J Sci Med Sport. 2015;18(5):575-80. [Crossref]  [PubMed] 
  53. Hall MC, Mockett SP, Doherty M. Relative impact of radiographic osteoarthritis and pain on quadriceps strength, proprioception, static postural sway and lower limb function. Ann Rheum Dis. 2006;65(7):865-70. [Crossref]  [PubMed]  [PMC] 
  54. Heidari B, Heidari P, Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop. 2011;35(11):1627-31. [Crossref]  [PubMed]  [PMC] 
  55. Felson DT, Niu J, Clancy M, Aliabadi P, Sack B, Guermazi A, et al. Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum. 2007;56(1):129-36. [Crossref]  [PubMed] 
  56. Zhang FF, Driban JB, Lo GH, Price LL, Booth S, Eaton CB, et al. Vitamin D deficiency is associated with progression of knee osteoarthritis. J Nutr. 2014;144(12):2002-8. [Crossref]  [PubMed]  [PMC] 
  57. McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. 20139;309(2):155-62. [Crossref]  [PubMed]  [PMC] 
  58. Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, et al. Effect of vitamin D supplementation on tibial cartilage volume and knee pain among patients with symptomatic knee osteoarthritis: a randomized clinical trial. JAMA. 20168;315(10):1005-13. [Crossref]  [PubMed] 
  59. Sanghi D, Mishra A, Sharma AC, Singh A, Natu SM, Agarwal S, et al. Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res. 2013;471(11):3556-62. [Crossref]  [PubMed]  [PMC] 
  60. Zheng S, Wang B, Han W, Zhu Z, Wang X, Jin X, et al. Vitamin D supplementation and inflammatory and metabolic biomarkers in patients with knee osteoarthritis: post hoc analysis of a randomised controlled trial. Br J Nutr. 2018;120(1):41-8. [Crossref]  [PubMed] 
  61. Zheng S, Jin X, Cicuttini F, Wang X, Zhu Z, Wluka A, et al. Maintaining vitamin D sufficiency is associated with improved structural and symptomatic outcomes in knee osteoarthritis. Am J Med. 2017;130(10):1211-8. [Crossref]  [PubMed] 
  62. Berkner KL. Vitamin K-dependent carboxylation. Vitam Horm. 2008;78:131-56. [Crossref]  [PubMed] 
  63. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21(1):142-4. [Crossref]  [PubMed] 
  64. Neogi T, Booth SL, Zhang YQ, Jacques PF, Terkeltaub R, Aliabadi P, et al. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006;54(4):1255-61. [Crossref]  [PubMed] 
  65. Oka H, Akune T, Muraki S, En-yo Y, Yoshida M, Saika A, et al. Association of low dietary vitamin K intake with radiographic knee osteoarthritis in the Japanese elderly population: dietary survey in a population-based cohort of the ROAD study. J Orthop Sci. 2009;14(6):687-92. [Crossref]  [PubMed] 
  66. Misra D, Booth SL, Tolstykh I, Felson DT, Nevitt MC, Lewis CE, et al. Vitamin K deficiency is associated with incident knee osteoarthritis. Am J Med. 2013;126(3):243-8. [Crossref]  [PubMed]  [PMC] 
  67. Shea MK, Kritchevsky SB, Hsu FC, Nevitt M, Booth SL, Kwoh CK, et al. The association between vitamin K status and knee osteoarthritis features in older adults: the Health, Aging and Body Composition Study. Osteoarthritis Cartilage. 2015;23(3):370-8. [Crossref]  [PubMed]  [PMC] 
  68. Neogi T, Felson DT, Sarno R, Booth SL. Vitamin K in hand osteoarthritis: results from a randomised clinical trial. Ann Rheum Dis. 2008;67(11):1570-3. [Crossref]  [PubMed]  [PMC] 
  69. Shea MK, Loeser RF, Hsu FC, Booth SL, Nevitt M, Simonsick EM, et al. Vitamin K status and lower extremity function in older adults: The Health Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2016;71(10):1348-55. [Crossref]  [PubMed]  [PMC] 
  70. Yan L, Zhou B, Greenberg D, Wang L, Nigdikar S, Prynne C, et al. Vitamin K status of older individuals in northern China is superior to that of older individuals in the UK. Br J Nutr. 2004;92(6):939-45. [Crossref]  [PubMed] 
  71. Thane CW, Paul AA, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ, et al. Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr. 2002;87(6):605-13. [Crossref]  [PubMed] 
  72. Shea MK, Booth SL. Concepts and controversies in evaluating vitamin K status in population-based studies. Nutrients. 2016;2;8(1):8. [Crossref]  [PubMed]  [PMC] 
  73. Suantawee T, Tantavisut S, Adisakwattana S, Tanavalee A, Yuktanandana P, Anomasiri W, et al. Oxidative stress, vitamin e, and antioxidant capacity in knee osteoarthritis. J Clin Diagn Res. 2013;7(9):1855-9. [Crossref]  [PubMed]  [PMC] 
  74. Jordan JM, De Roos AJ, Renner JB, Luta G, Cohen A, Craft N, et al. A case-control study of serum tocopherol levels and the alpha- to gamma-tocopherol ratio in radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. Am J Epidemiol. 2004;15;159(10):968-77. [Crossref]  [PubMed] 
  75. Bhattacharya I, Saxena R, Gupta V. Efficacy of vitamin E in knee osteoarthritis management of North Indian geriatric population. Ther Adv Musculoskelet Dis. 2012;4(1):11-9. [Crossref]  [PubMed]  [PMC] 
  76. Pearson P, Lewis SA, Britton J, Young IS, Fogarty A. The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs. 2006;20(5):271-3. [Crossref]  [PubMed] 
  77. Tafazoli S, Wright JS, O'Brien PJ. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem Res Toxicol. 2005;18(10):1567-74. [Crossref]  [PubMed] 
  78. Thomas S, Browne H, Mobasheri A, Rayman MP. What is the evidence for a role for diet and nutrition in osteoarthritis? Rheumatology (Oxford). 2018;1;57(suppl_4):iv61-iv74. [Crossref]  [PubMed]  [PMC] 
  79. Chin KY, Ima-Nirwana S. The role of vitamin E in preventing and treating osteoarthritis- a review of the current evidence. Front Pharmacol. 2018;21;9:946. [Crossref]  [PubMed]  [PMC] 
  80. Kurz B, Jost B, Schünke M. Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice. Osteoarthritis Cartilage. 2002;10(2):119-26. [Crossref]  [PubMed] 
  81. McAlindon TE, Jacques P, Zhang Y, Hannan MT, Aliabadi P, Weissman B, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum. 1996;39(4):648-56. [Crossref]  [PubMed] 
  82. Sowers M, Lachance L. Vitamins and arthritis. The roles of vitamins A, C, D, and E. Rheum Dis Clin North Am. 1999;25(2):315-32. [Crossref]  [PubMed] 
  83. Peregoy J, Wilder FV. The effects of vitamin C supplementation on incident and progressive knee osteoarthritis: a longitudinal study. Public Health Nutr. 2011;14(4):709-15. [Crossref]  [PubMed] 
  84. Chaganti RK, Tolstykh I, Javaid MK, Neogi T, Torner J, Curtis J, et al. High plasma levels of vitamin C and E are associated with incident radiographic knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(2):190-6. [Crossref]  [PubMed]  [PMC] 
  85. Messina OD, Vidal Wilman M, Vidal Neira LF. Nutrition, osteoarthritis and cartilage metabolism. Aging Clin Exp Res. 2019;31(6):807-13. [Crossref]  [PubMed] 
  86. Hunter DJ, Hart D, Snieder H, Bettica P, Swaminathan R, Spector TD, et al. Evidence of altered bone turnover, vitamin D and calcium regulation with knee osteoarthritis in female twins. Rheumatology (Oxford). 2003;42(11):1311-6. [Crossref]  [PubMed] 
  87. Zhang Y, Xu J, Qin L, Jiang Q. Magnesium and osteoarthritis: from a new perspective. Ann Joint. 2016;1(10):29. [Crossref] 
  88. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol. 1992;263(3 Pt 2):R734-7. [Crossref]  [PubMed] 
  89. Zeng C, Li H, Wei J, Yang T, Deng ZH, Yang Y, et al. Association between dietary magnesium intake and radiographic knee osteoarthritis. PLoS One. 2015;26;10(5):e0127666. [Crossref]  [PubMed]  [PMC] 
  90. Shmagel A, Onizuka N, Langsetmo L, Vo T, Foley R, Ensrud K, et al. Low magnesium intake is associated with increased knee pain in subjects with radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage. 2018;26(5):651-8. [Crossref]  [PubMed] 
  91. Downey CM, Horton CR, Carlson BA, Parsons TE, Hatfield DL, Hallgrímsson B, et al. Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS Genet. 2009;5(8):e1000616. [Crossref]  [PubMed]  [PMC] 
  92. Li S, Xiao T, Zheng B. Medical geology of arsenic, selenium and thallium in China. Sci Total Environ. 2012;1;421-422:31-40. [Crossref]  [PubMed] 
  93. Kim JH, Jeon J, Shin M, Won Y, Lee M, Kwak JS, et al. Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell. 2014;13;156(4):730-43. [Crossref]  [PubMed] 
  94. Vinatier C, Merceron C, Guicheux J. Osteoarthritis: from pathogenic mechanisms and recent clinical developments to novel prospective therapeutic options. Drug Discov Today. 2016;21(12):1932-7. [Crossref]  [PubMed] 
  95. Radakovich LB, Marolf AJ, Santangelo KS. 'Iron accumulation' gene expression profile in obese hartley guinea pig knee joints is associated with more severe osteoarthritis. Osteoarthritis Cartilage.2017;25(11):169. [Crossref] 
  96. Heaney RP. Dairy and bone health. J Am Coll Nutr. 2009;28 Suppl 1:82S-90S. [Crossref]  [PubMed] 
  97. Bonjour JP, Kraenzlin M, Levasseur R, Warren M, Whiting S. Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health. J Am Coll Nutr. 2013;32(4):251-63. [Crossref]  [PubMed]  [PMC] 
  98. Kaçar C, Gilgil E, Tuncer T, Bütün B, Urhan S, Sünbüloglu G, et al. The association of milk consumption with the occurrence of symptomatic knee osteoarthritis. Clin Exp Rheumatol. 2004;22(4):473-6. [PubMed] 
  99. Lu B, Driban JB, Duryea J, McAlindon T, Lapane KL, Eaton CB, et al. Milk consumption and progression of medial tibiofemoral knee osteoarthritis: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken). 2014;66(6):802-9. [Crossref]  [PubMed]  [PMC] 
  100. Denissen KFM, Boonen A, Nielen JTH, Feitsma AL, van den Heuvel EGHM, Emans PJ, et al. Consumption of dairy products in relation to the presence of clinical knee osteoarthritis: The Maastricht Study. Eur J Nutr. 2019;58(7):2693-2704. [Crossref]  [PubMed]  [PMC] 
  101. Figueira ME, Câmara MB, Direito R, Rocha J, Serra AT, Duarte CM, et al. Chemical characterization of a red raspberry fruit extract and evaluation of its pharmacological effects in experimental models of acute inflammation and collagen-induced arthritis. Food Funct. 2014;5(12):3241-51. [Crossref]  [PubMed] 
  102. Figueira ME, Oliveira M, Direito R, Rocha J, Alves P, Serra AT, et al. Protective effects of a blueberry extract in acute inflammation and collagen-induced arthritis in the rat. Biomed Pharmacother. 2016;83:1191-1202. [Crossref]  [PubMed] 
  103. Veronese N, Stubbs B, Noale M, Solmi M, Luchini C, Smith TO, et al. Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative. Clin Nutr. 2017;36(6):1609-14. [Crossref]  [PubMed]  [PMC] 
  104. Dyer J, Davison G, Marcora SM, Mauger AR. Effect of a mediterranean type diet on ınflammatory and cartilage degradation biomarkers in patients with osteoarthritis. J Nutr Health Aging. 2017;21(5):562-6. [Crossref]  [PubMed]  [PMC] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com